bmy 7378 and Cardiomegaly

bmy 7378 has been researched along with Cardiomegaly in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Andrade-Jorge, E; Estrada-Soto, SE; Gallardo-Ortíz, IA; Jiménez-Flores, JR; Martínez-Aguilar, L; Ramírez-Hernández, D; Rodríguez, JE; Saucedo-Campos, AD; Touyz, RM; Vega, AV; Villalobos-Molina, R1
Katus, HA; Kemken, D; Kurz, T; Mier, K; Richardt, G1

Other Studies

2 other study(ies) available for bmy 7378 and Cardiomegaly

ArticleYear
The α1D-adrenoreceptor antagonist BMY 7378 reverses cardiac hypertrophy in spontaneously hypertensive rats.
    Journal of hypertension, 2020, Volume: 38, Issue:8

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiomegaly; Heart; Piperazines; Rats; Rats, Inbred WKY

2020
Adrenergic activation of cardiac phospholipase D: role of alpha(1)-adrenoceptor subtypes.
    Cardiovascular research, 2002, Volume: 54, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Clonidine; Dioxanes; Male; Myocardium; Norepinephrine; Perfusion; Phospholipase D; Piperazines; Prazosin; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Signal Transduction; Stimulation, Chemical

2002